Welcome to the New HCVGuidelines.org
The AASLD and IDSA in partnership with the panel have created an updated web experience to facilitate easier and faster access to this important resource. Please select a patient profile from the menu above, click on a Guidance section below, or use the search box to begin.
Contents and Introduction - Select a Page
- Full Table of Contents
- Introduction
- Methods
- Methods: Table 1 - Summary of the Process and Methods for the Guidance Development
- Methods: Table 2 - Rating System Used to Rate the Level of the Evidence and Strength of the Recommendation for Each Recommendation
- Methods: Table 3 - Commonly Used Abbreviations and Their Expansions
- References
Testing, Evaluation, and Monitoring of Hepatitis C - Browse Topics
- Testing, Evaluation, and Monitoring of Hepatitis C
- HCV Testing and Linkage to Care
- When and in Whom to Initiate HCV Therapy
- Overview of Cost, Reimbursement, and Cost-effectiveness Considerations for Hepatitis C Treatment Regimens
- Monitoring Patients Who Are Starting HCV Treatment, Are on Treatment, or Have Completed Therapy
- Not Recommended Regimens In HCV Treatment
Using the Guidance on Your Mobile Device
 |
Add a bookmark to your home screen:
|
 |
Add a bookmark to your home screen:
|
